If you or a loved one were diagnosed with Hepatocellular Carcinoma, Hepatoma or HCC liver cancer after taking Zantac (Ranitidine), you may be entitled to recover compensation from a Zantac Hepatocellular Carcinoma lawsuit case or settlement claim.
A team of heartburn drug injury lawyers and class action attorneys is investigating potential lawsuit and settlement cases of individuals who claim to have been diagnosed with Hepatoma or Hepatocellular Carcinoma after taking Zantac (Ranitidine).
Hepatocellular Carcinoma (HCC or hepatoma) is a primary malignant tumor of the liver that results from the malignant transformation of hepatocytes (hepatic parenchymal liver tissue cells that are involved with synthesizing proteins, storing protein, transforming carbohydrates, synthesizing bile salts, phospholipids and cholesterol, producing and secreting bile, and detoxifying and excreting susbtances).
Hepatocellular Carcinoma is the most common type of adult liver cancer, comprising about 85-90 percent of all liver cancer cases. Hepatoma affects about twice as many males as females. Hepatocellular Carcinoma is one of the leading causes of cancer-related deaths worldwide.
Zantac Hepatocellular Carcinoma Lawsuit Cases
Zantac hepatocellular carcinoma lawsuit and settlement cases potentially being investigated include claims of individuals who took recalled Zantac or ranitidine and suffered serious injuries, side-effects or complications including, among others:
- Hepatocellular Carcinoma (HCC)
- HCC cancer
- Hepatoma
- Liver cell carcinoma
- Macrotrabecular-massive hepatocellular carcinoma (MTM-HCC)
- Steatohepatitic hepatocellular carcinoma (SH-HCC)
- Clear cell hepatocellular carcinoma
- Lymphocyte-rich hepatocellular carcinoma
- Scirrhous hepatocellular carcinoma
- Fibrolamellar hepatocellular carcinoma (FLC)
- Trabecular hepatocellular carcinoma
- Pseudoglandular hepatocellular carcinoma
- Compact hepatocellular carcinoma
- Undifferentiated hepatocellular carcinoma
- Lymphoepithelioma-like carcinoma
- Sarcomatoid hepatocellular carcinoma
- Cirrhotomimetic hepatocellular carcinoma
- Granulocyte colony-stimulating factor producing HCC
- Hepatocellular-cholangiocarcinoma (cHCC-CCA)
- Other types of HCC liver cancer
If you or someone you love took Zantac or Ranitidine and have suffered from Hepatoma or Hepatocellular Carcinoma, you may be entitled to compensation from a Zantac Hepatocellular Carcinoma lawsuit or settlement. Contact a drug injury lawyer to request a free case review.
*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.
**The listing of a company (e.g., Sandoz, Pfizer, GlaxoSmithKline, Sanofi, Apotex, Perrigo, Lannett or Novitium) or product (e.g., Zantac or Ranitidine) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.
***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.
Fill out the form for a free attorney review.